# Cancer Immunotherapy

## 1. **Cancer Immunotherapy**

* [**2024 Cell** ](https://doi.org/10.1016/j.ccell.2024.04.008)- Comprehensive peripheral blood immunoprofiling reveals five immunotypes with immunotherapy response characteristics in patients with cancer&#x20;
* **2024 Cancer Cell** - Integrated multi-omics profiling to dissect thespatiotemporal evolution of metastatichepatocellular carcinoma
* **\[review] 2023 Cell** - Delivering the next generation of cancer immunotherapies with RNA
* **2023 Cancer Cell** - ZNF683 marks a CD8+ T cell population associated with anti-tumor immunity following anti-PD-1 therapy for Richter syndrome
* **2023 Cancer Cell** - The pre-existing T cell landscape determines the response to bispecific T cell engagers in multiple myeloma patients
* ✅ (neoadjuvant biomarker) [_**2022 Mol. Cancer**_ ](https://doi.org/10.1186/s12943-022-01684-9)- A liquid biopsy signature of circulating exosome-derived mRNAs, miRNAs and lncRNAs predict therapeutic efficacy to neoadjuvant chemotherapy in patients with advanced gastric cancer
* ✅ (neoadjuvant) **2022&#x20;**_**Cell**_ - Tissue-resident memory and circulating T cells are early responders to pre-surgical cancer immunotherapy
* (neoadjuvant) **2022 Nature Med  -** Genomic and transcriptomic determinants of response to neoadjuvant therapy in rectal cancer
* **2021 Cancer Cell** - Single-cell analyses reveal key immune cell subsets associated with response to PD-L1 blockade in triple-negative breast cancer
* (non-neo adjuvant) **2021** _**Nature -**_ ctDNA guiding adjuvant immunotherapy in urothelial carcinoma
* **2020 Science Advance** - Multi-omics characterization of molecular features of gastric cancer correlated with response to neoadjuvant chemotherapy

## 2. Cancer microenvironment

* _**2019 - Nat Genetics**_ - Landscape of B cell immunity and related immune evasion in human cancers
* _**2018 - Nat Biotech**_ - Evaluation of immune repertoire inference methods from RNA-seq data
* _**2016 - Nature Genetics**_ - Landscape of tumor-infiltrating T cell repertoire of human cancers
* \[srpRNA] **2021&#x20;**_**Cell**_ - The immunostimulatory RNA RN7SL1 enables CAR-T cells to enhance autonomous and endogenous immune function
* \[srpRNA] _**2017 Cell**_ - Exosome RNA Unshielding Couples Stromal Activation to Pattern Recognition Receptor Signaling in Cancer

## 3. Neoantigen

* \[review] _**2021 Nature**_ - Advances in the development of personalized neoantigen-based therapeutic cancer vaccines
* \[review] _**2017 Cell**_ - Applications of Immunogenomics to Cancer
* _**2020 NCOMM**_ - Integrated genomic analysis reveals mutated ELF3 as a potential gallbladder cancer vaccine candidate
